Vio3/Apc3/Erbejet2
Payments companies reported to CMS as associated with Vio3/Apc3/Erbejet2. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vio3/Apc3/Erbejet2, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vio3/Apc3/Erbejet2
These are the largest totals companies reported as associated with Vio3/Apc3/Erbejet2. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Emily Speer | Wheat Ridge, CO | Surgery | $115.35 |
| Edward Jones | Denver, CO | Surgery | $115.35 |
| Neil Toribara | Denver, CO | Gastroenterology (Internal Medicine) | $115.35 |
| Courtenay Ryan-Fisher | Torrington, CT | Gastroenterology (Internal Medicine) | $22.50 |
| Akaash Mittal | Farmington, CT | Internal Medicine | $22.50 |
Prescribed Vio3/Apc3/Erbejet2?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.